WaveLight today announced that it has received approval from the U.S. Food and Drug Administration to treat mixed astigmatism with the wavefront-optimized Allegretto Wave excimer laser system.
More: continued here
You can respond, or trackback from your own site.
Name (required)
Mail (will not be published) (required)
Website